Heron Therapeutics, Inc. HRTX
Set alert
0.30 USD +0.02 +6.27%
At close
0.30 0.00 +1.59%
Pre-market · Nov 3, 5:32 AM ET
0.275 Day range 0.2995
0.26 52-week range 1.58
- YTD
- -77.30%
- 1 year
- -74.99%
- Open
- 0.2799
- Prev close
- 0.2777
- Mkt cap
- 56.03M
- Vol
- 1.22M
- Avg vol
- 2.48M
- EPS
- -0.18
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.275
- High
- 0.2995
- Forward P/E
- 0.00
- Beta
- 1.81
- Short ratio
- 14.20
- Inst. own
- 81.53%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.57
- 200-d avg
- 2.42
- 1y target
- 6.00
Analyst view
Consensus: none
Price target (mean) 6.00 +1933.2% upside
Now 0.2951
- Target (low)
- 4.00
- Target (mean)
- 6.00
- Target (high)
- 9.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy1
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.025 | -0.03 – -0.02 | -0.07 | +64.3% | 37.37M | +9.2% | 2 |
| Next quarter | 0.00 | 0.00 – 0.00 | -0.02 | 0.0% | 0 | 0.0% | 0 |
| Current year | -0.12 | -0.14 – -0.09 | -0.80 | +85.0% | 140.87M | +10.9% | 2 |
| Next year | -0.01 | -0.05 – 0.03 | -0.12 | +91.7% | 167.30M | +18.8% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 4, 2024 | Needham | Reiterated | Buy | Buy |
| Nov 13, 2024 | Needham | Maintained | Buy | Buy |
| Sep 25, 2024 | Needham | Reiterated | Buy | Buy |
| Aug 7, 2024 | Needham | Reiterated | Buy | Buy |
| Jun 13, 2024 | Rodman & Renshaw | Initiated | — | Buy |
| May 16, 2024 | Needham | Reiterated | Buy | Buy |
| May 8, 2024 | Needham | Reiterated | Buy | Buy |
| Apr 23, 2024 | Capital One | Initiated | — | Overweight |
| Apr 11, 2024 | Needham | Reiterated | Buy | Buy |
| Mar 13, 2024 | Needham | Maintained | Buy | Buy |
| Nov 15, 2023 | Needham | Maintained | Buy | Buy |
| Aug 15, 2023 | Needham | Reiterated | Buy | Buy |
| Jul 25, 2023 | Needham | Maintained | Buy | Buy |
| May 12, 2023 | Needham | Maintained | Buy | Buy |
| Apr 21, 2023 | Needham | Reiterated | — | Buy |
| Mar 24, 2023 | Evercore ISI Group | Maintained | — | Outperform |
| Mar 24, 2023 | Needham | Maintained | — | Buy |
| Nov 9, 2022 | Needham | Maintained | — | Buy |
| Jun 30, 2022 | Needham | Maintained | — | Buy |
| May 10, 2022 | Needham | Maintained | — | Buy |
| Dec 2, 2020 | SVB Leerink | Maintained | — | Outperform |
| May 27, 2020 | Guggenheim | Initiated | — | Buy |
| Mar 2, 2020 | Needham | Maintained | — | Buy |
| Feb 20, 2020 | Needham | Maintained | — | Buy |
| Oct 3, 2019 | JMP Securities | Reiterated | — | Market Outperform |
| Sep 14, 2018 | Stifel | Initiated | — | Buy |
| Jul 19, 2018 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Jun 22, 2018 | Oppenheimer | Maintained | Outperform | Outperform |
| Jun 21, 2018 | Evercore ISI Group | Maintained | — | Outperform |
| Jan 3, 2018 | Leerink Swann | Initiated | — | Outperform |